2018
DOI: 10.5858/arpa.2018-0291-ra
|View full text |Cite
|
Sign up to set email alerts
|

Ovarian Sex Cord–Stromal Tumors: Reflections on a 40-Year Experience With a Fascinating Group of Tumors, Including Comments on the Seminal Observations of Robert E. Scully, MD

Abstract: Context.— This year being the 60th anniversary of the publication of the excellent book Endocrine Pathology of the Ovary by John McLean Morris, MD, and Robert E. Scully, MD, the writer reflects on that work and in particular the remarkable contributions of its second author to our knowledge in this area. Objective.— To review ovarian sex cord–stromal tumors. Data Sources.— … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(28 citation statements)
references
References 60 publications
(46 reference statements)
0
28
0
Order By: Relevance
“…The classic morphological and immunohistochemical features of AGCT have been extensively reviewed recently and will not be repeated here . Given the broad spectrum of growth patterns and cytological effects of luteinisation in AGCTs (Figure A–C), these tumours may mimic a diverse array of epithelial, germ cell and other sex cord–stromal tumours; this has also been recently reviewed .…”
Section: Agct and Foxl2mentioning
confidence: 99%
See 1 more Smart Citation
“…The classic morphological and immunohistochemical features of AGCT have been extensively reviewed recently and will not be repeated here . Given the broad spectrum of growth patterns and cytological effects of luteinisation in AGCTs (Figure A–C), these tumours may mimic a diverse array of epithelial, germ cell and other sex cord–stromal tumours; this has also been recently reviewed .…”
Section: Agct and Foxl2mentioning
confidence: 99%
“…The classic morphological and immunohistochemical features of AGCT have been extensively reviewed recently and will not be repeated here. [31][32][33] Given the broad spectrum of growth patterns and cytological effects of luteinisation in AGCTs ( Figure 1A-C), these tumours may mimic a diverse array of epithelial, germ cell and other sex cord-stromal tumours; this has also been recently reviewed. 33,34 Therefore, we recommend immunohistochemical confirmation of all cases of AGCT by the use of sex cord-stromal markers (FOXL2, SF-1, calretinin, and or inhibin) and, as appropriate, additional markers relevant to the differential diagnosis.…”
Section: Scenario 1: Agct With Classic Morphology and Immunophenotypementioning
confidence: 99%
“…Most lesions are clinically benign, with some patients (20%) showing low-grade malignancy. 36 Our patient was confirmed to have non-PJS SCTAT presenting with multiple lesions. The Ki-67 concentration was relatively low, but the degree of malignancy was high with multiple recurrences and metastases.…”
Section: Discussionmentioning
confidence: 63%
“…The histopathological morphology of this tumor varies with the relative prominence of 3 components: microcysts (dominant in 60% of cases), solid cellular regions, and hyalinized fibrous stroma. [ 2 ] Based on personal experience of Young, [ 3 ] the tumor cells usually have lightly eosinophilic cytoplasm and bland nuclei, but bizarre nuclei are present in 60% of the cases. Microcystic stromal tumors have a distinctive immunoprofile.…”
Section: Introductionmentioning
confidence: 99%
“…They are typically negative for inhibin, calretinin, but diffuse positive for beta-catenin, cyclin D1, WT-1, FOXL2, and SF-1. [ 4 ] Some pathologists think that this tumor may not be truly related to ovarian stromal origin but is, for now, placed in the stromal family as the “best fit.” [ 3 ] However, there is no specific description about the degree and area of bizarre nuclei in MCST in the English literatures. Here, we report a case of ovarian MCST with significant bizarre nuclei accounting for about 50% of the tumor cells.…”
Section: Introductionmentioning
confidence: 99%